FMTVDM Quantitative Nuclear Imaging finds Three Treatments for SARS-CoV-2

“Introduction: This investigation studied 10 different treatments and 52 treatment combinations to determine if there is an effective treatment regimen for SARS-CoV-2…

Methods: 1800 people testing positive for SARS-CoV-2 from 23 sites in 7 countries were studied including outpatient and inpatient care and treatment…

Results: Of the 1800 patients seeking medical care, 847 received no outpatient treatment with 59.5 % recovering and 40.5 % requiring hospitalization. Of the 953 treated with an aminoquinoline in the outpatient setting, 16.6 % required further treatment and hospitalization… During Phase II of the study patients receiving combination treatments consisting of one of three regimens focusing on treating the immune ITR to SARS-CoV-2 responded 99.83 % of the time. These three ITR regimens consisted of

1. Tocilizumab & Interferon a-2b
2. Primaquine, Clindamycin, Tocilizumab & Interferon a-2b, and
3. Methylprednisolone.

Conclusion: The answer to the question is, Yes. The treatment of SARS-CoV-2, like HIV, requires a multi-drug treatment regimen focusing on the immune ITR to SARSCoV- 2…

These three regimens were effective 99.83 % of the time and shortened hospital stays from 40 ± 3 days to 1-2 weeks.”